JP2010524965A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524965A5
JP2010524965A5 JP2010504257A JP2010504257A JP2010524965A5 JP 2010524965 A5 JP2010524965 A5 JP 2010524965A5 JP 2010504257 A JP2010504257 A JP 2010504257A JP 2010504257 A JP2010504257 A JP 2010504257A JP 2010524965 A5 JP2010524965 A5 JP 2010524965A5
Authority
JP
Japan
Prior art keywords
alkyl
halogen
hydroxy
hydrogen
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010504257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524965A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/060710 external-priority patent/WO2008131148A1/en
Publication of JP2010524965A publication Critical patent/JP2010524965A/ja
Publication of JP2010524965A5 publication Critical patent/JP2010524965A5/ja
Pending legal-status Critical Current

Links

JP2010504257A 2007-04-19 2008-04-18 ジフェニル−ヘテロアリール誘導体並びにアミロイド斑への結合及び画像化のためのその使用 Pending JP2010524965A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90784107P 2007-04-19 2007-04-19
US92980607P 2007-07-13 2007-07-13
PCT/US2008/060710 WO2008131148A1 (en) 2007-04-19 2008-04-18 Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques

Publications (2)

Publication Number Publication Date
JP2010524965A JP2010524965A (ja) 2010-07-22
JP2010524965A5 true JP2010524965A5 (enExample) 2011-06-02

Family

ID=39875907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504257A Pending JP2010524965A (ja) 2007-04-19 2008-04-18 ジフェニル−ヘテロアリール誘導体並びにアミロイド斑への結合及び画像化のためのその使用

Country Status (4)

Country Link
US (1) US20110158907A1 (enExample)
EP (1) EP2144507A4 (enExample)
JP (1) JP2010524965A (enExample)
WO (1) WO2008131148A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2109364A4 (en) 2006-12-15 2010-04-14 Abbott Lab NOVEL OXADIAZONE COMPOUNDS
EP2247558B2 (en) 2008-02-14 2024-07-03 Eli Lilly and Company Novel imaging agents for detecting neurological dysfunction
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
EP2304366A2 (en) * 2008-05-30 2011-04-06 Foster Wheeler Energia Oy Method of and system for generating power by oxyfuel combustion
EP2687513B1 (en) 2008-06-09 2020-12-02 Ludwig-Maximilians-Universität München Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
JP2011529086A (ja) 2008-07-24 2011-12-01 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Ad病変を同定するために有用な造影剤
WO2010071741A1 (en) * 2008-12-16 2010-06-24 Merck Sharp & Dohme Corp. Triazole derivatives for treatment of alzheimer's disease
JP2012521988A (ja) 2009-03-23 2012-09-20 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド 神経学的障害を検知するためのイメージング剤
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
GB0921573D0 (en) * 2009-12-10 2010-01-27 Ge Healthcare Ltd Iodine radiolabelling method
WO2012118935A1 (en) 2011-03-03 2012-09-07 Proteotech Inc Compounds for the treatment of neurodegenerative diseases
US20120251448A1 (en) * 2011-03-03 2012-10-04 Hefti Franz F Compounds for Use in the Detection of Neurodegenerative Diseases
MX2017006136A (es) 2014-12-15 2017-07-19 Dow Agrosciences Llc Moleculas que tienen utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas.
JP7283699B2 (ja) 2017-05-12 2023-05-30 マックス-プランク-ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 黒色腫の治療または予防において使用するためのフェニル-ヘテロ環-フェニル誘導体
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN111217752A (zh) * 2020-02-12 2020-06-02 温州市人民医院 芳基吡唑类化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2856311A (en) * 1952-05-21 1958-10-14 Ciba Ltd Process for optically brightening fibrous materials
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US5235044A (en) * 1992-09-09 1993-08-10 Raychem Corporation Compounds having oxadiazole and triazene moieties, crosslinkable polymers therefrom, and methods therefor
DE19816880A1 (de) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
ATE257827T1 (de) * 1999-07-21 2004-01-15 Hoffmann La Roche Triazolderivate
TW200413009A (en) * 2002-10-04 2004-08-01 Univ Pennsylvania Biphenyls and fluorenes as imaging agents in alzheimer's disease
JP2008546804A (ja) * 2005-06-24 2008-12-25 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 造影剤として用いるためのリガンドの放射性標識ペグ化
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses

Similar Documents

Publication Publication Date Title
JP2010524965A5 (enExample)
JP2018502902A5 (enExample)
JP2014515406A5 (enExample)
JP2013523897A5 (enExample)
JP2013507423A5 (enExample)
JP2010524857A5 (enExample)
JP2008538381A5 (enExample)
JP2004516314A5 (enExample)
JP2018518201A5 (enExample)
CA2479109A1 (en) Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
JP2008525416A5 (enExample)
JP2008195730A5 (enExample)
JP2018511628A5 (enExample)
JP2013514367A5 (enExample)
JP2016006118A5 (enExample)
JP2019519467A5 (enExample)
JP2012515776A5 (enExample)
JP2019535754A5 (enExample)
JP2011520815A5 (enExample)
JP2005526857A5 (enExample)
JP2012149030A5 (ja) 化合物
RU2008150377A (ru) Новое соединение, обладающее сродством к амилоиду
JP2006528205A5 (enExample)
JP2014515349A5 (enExample)
JP2008536833A5 (enExample)